Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Genetic Associations and Epidemiology, and Cancer, Lipids, and Metabolism.
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons.
VLDL cholesterol and ASCVD risk: A population-based study
High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study.
Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease.
Residual lipid risk in atherosclerotic cardiovascular disease.
Risk of Atherosclerotic Cardiovascular Disease in Familial Remnant Hyperlipidemia (Dysbetalipoproteinemia) and Familial Hypercholesterolemia.
Hellenic Postprandial Lipemia Study (HPLS): A Prospective Cohort Trial on the Effect of Statins on Postprandial Hypertriglyceridemia.
Essential to identify high lipoprotein(a) in children with hypercholesterolaemia.
Remnant cholesterol reduction for reduction of residual ASCVD risk.
Low-density lipoprotein cholesterol and risk of COPD: a Mendelian randomization study.
Impact of Variation in APOE on Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Sequencing and Genotyping in General Population Cohorts.
JCL roundtable: European perspective on comprehensive lipid management and cardiovascular health.
High lipoprotein(a) and high BMI jointly confer the highest risk of ASCVD in both primary and secondary prevention.
Alpha-1 antitrypsin deficiency and cardiovascular disease: a review.
Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography.
Combination of cardioprotective glucose-lowering drugs and statins on cardiovascular mortality in diabetes: a nationwide cohort study.
Incidentally Detected Splenomegaly and Risk of Hematologic Cancer and Liver Disease.
Osteoarthritis and analgesic consumption in haemochromatosis HFE C282Y homozygotes with normal or low iron parameters.
C282Y Homozygosity Increases Erythrocyte Turnover and Decreases HbA1c-A Population-Based Study.
Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies.
Low-density lipoprotein cholesterol, coronary plaque burden, and myocardial infarction in adults aged 76-92 years: The Western Denmark Heart Registry.
Cardiovascular risk among Giant cells arteritis patients.
Plasma levels of lipoprotein(a) in persons with HIV compared to the general population.
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.
Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias